Market closed

Harrow Health/$HROW

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Harrow Health

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans.

Ticker

$HROW
Trading on

Industry

Pharmaceuticals

Employees

315

Harrow Health Metrics

BasicAdvanced
$1.2B
Market cap
-
P/E ratio
-$0.94
EPS
0.76
Beta
-
Dividend rate
$1.2B
0.76
$56.01
$9.13
556K
1.548
1.347
339.385
340.265
-0.40%
-1.68%
-50.23%
7.192
21.2
21.2
-8.204
48.15%
103.44%
36.24%
35.39%

What the Analysts think about Harrow Health

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Harrow Health stock.

Harrow Health Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Harrow Health Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $HROW

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Harrow Health stock?

Harrow Health (HROW) has a market cap of $1.2B as of December 21, 2024.

What is the P/E ratio for Harrow Health stock?

The price to earnings (P/E) ratio for Harrow Health (HROW) stock is 0 as of December 21, 2024.

Does Harrow Health stock pay dividends?

No, Harrow Health (HROW) stock does not pay dividends to its shareholders as of December 21, 2024.

When is the next Harrow Health dividend payment date?

Harrow Health (HROW) stock does not pay dividends to its shareholders.

What is the beta indicator for Harrow Health?

Harrow Health (HROW) has a beta rating of 0.76. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.